Fibrillogenesis

Picotti P, Franceschi GD, Frare E, Spolaore B, Zambonin M, et al. (2007) Amyloid fibril formation and disaggregation of fragment 1-29 of apomyoglobin: insights into the effect of pH on protein fibrillogenesis. ❋ Carlene S. Starck Et Al. (2010)

Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, et al. (1999) Amyloid β-protein fibrillogenesis. ❋ Carlene S. Starck Et Al. (2010)

The in vitro formation of MstnPP aggregates and amyloid species suggests a similar phenomenon could occur in vivo having a negative effect on cell viability and/or assisting in Aβ fibrillogenesis. ❋ Carlene S. Starck Et Al. (2010)

The ellipticity for the spectrum is comparatively low, similar to that observed in the fibrillogenesis of Aβ ❋ Carlene S. Starck Et Al. (2010)

Wypych J, Steavenson S, Louis JC, Citron M, et al. (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. ❋ Diane Latawiec Et Al. (2010)

Chatechol derivatives including dopamine have been shown to inhibit AS fibrillogenesis causing accumulation of oligomeric species, ❋ Fernando E. Herrera Et Al. (2008)

Previous studies have established the ratio of Aβ40 to Aβ42 as an important factor in determining the fibrillogenesis, toxicity, and pathological distribution of Aβ. ❋ A. Jan (2008)

Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, et al. (2003) Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. ❋ Unknown (2008)

Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. ❋ Tao Yang Et Al. (2008)